IBAC IB Acquisition Corp.
Services-Commercial Physical & Biological Research · Nasdaq · SEC CIK 1998781 · Fiscal year ends 09/30
Financial factors as of 2026-03-31 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-74.6%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA1.5%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets21.7%
Debt / equity—
Current ratio0.16x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-1.54x
Accruals ratio3.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-09-30 | FY20242024-09-30 | FY20232023-09-30 |
|---|---|---|---|
| Income statement | |||
| Revenue | — | — | — |
| SG&A expense | $748,908 | $523,974 | $6,844 |
| Operating income | -$748,908 | -$523,974 | -$6,844 |
| Interest expense | — | -$3.03M | — |
| Pretax income | $4.38M | $2.50M | -$6,844 |
| Income tax | $965,635 | $635,512 | — |
| Net income | $3.42M | $1.87M | -$6,844 |
| EPS (diluted) | — | — | — |
| Balance sheet | |||
| Cash & equivalents | $428,700 | $822,799 | $52,553 |
| Current assets | $1.24M | $1.20M | $52,553 |
| Total assets | $17.13M | $119.80M | $52,553 |
| Current liabilities | $1.83M | $722,230 | $57,987 |
| Total liabilities | $1.83M | $722,230 | $57,987 |
| Shareholders' equity | -$681,323 | $1.11M | -$5,434 |
| Shares outstanding | 4.25M | 4.25M | 3.24M |
| Cash flow statement | |||
| Operating cash flow | -$1.32M | -$820,959 | -$207 |
| Investing cash flow | $107.84M | -$115.58M | — |
| Financing cash flow | -$106.13M | $117.17M | $50,000 |
| Share buybacks | $106.13M | — | — |
· This company does not report gross profit in XBRL.
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.